Quick FDA Update on Covid-19 Activities

The U.S. Food and Drug Administration (FDA) gave an update on its activities regarding the novel coronvirus (COVID-19), which are focused on efforts to facilitate diagnose, treat and prevent the disease. The agency is also surveilling the medical product supply chain for potential shortages or disruptions and helping to mitigate impacts.

The FDA is not currently conducting inspections in China in response to the U.S. Department of State’s Travel Advisory to not travel to China due to the novel coronavirus outbreak. The FDA pulled its inspectors back to the U.S., but said when the travel advisory is changed, the agency will resume routine inspections as soon as feasible. Read the complete announcement here.

Recent Posts

See All

KEI Medical Imaging Services Statement on COVID-19

With the ever-changing COVID-19 situation, KEI Medical Imaging Services is committed to the continuity of our business and maintaining the highest levels of customer service and satisfaction. We are o

Knowledge, Experience, Integrity

248 Investment Loop

Hutto, TX  78634

Tel: 512.477.1500

Office Hours: 9 am -  6 pm (Central)

Service and Parts:

Member of IAMERS (International Association of Medical Equipment Remarketers and Servicers)